Health and Healthcare

Geron : GERN

All Geron Articles

78 Articles

Chris Lange | Oct 31, 2017 at 11:25 AM EDT

Can This FDA Approval Keep Lifting Geron?

Geron is one of the few biopharma winners on Tuesday, with the health care sector in general pushing slightly lower…

Chris Lange | Sep 18, 2016 at 10:20 AM EDT

4 Companies That Destroyed Shareholders Last Week

24/7 Wall Street has picked out a few companies posting the largest losses for the week, including Novavax and VimpelCom.

Paul Ausick | Sep 12, 2016 at 4:04 PM EDT

Kroger, Whole Foods in Monday’s 52-Week Low Club

September 12, 2016: Here are four stocks trading with relatively heavy volume among 56 equities making new 52-week lows in…

Jon C. Ogg | Sep 12, 2016 at 12:45 PM EDT

Is Geron Being Overly Punished?

Investors never like to see a stock they own drop 17%, but there is at least one view that maybe…

Jon C. Ogg | May 23, 2016 at 8:05 AM EDT

10 Speculative Biotech and Biohealth Stocks With Massive Analyst Upside Calls

Biotech is the one arena that still offers massive upside for investors — if they can pick the right companies…

Jon C. Ogg | May 8, 2016 at 10:35 AM EDT

Can Geron Shares Still Ultimately Double?

A research report from Janney's Roy Buchanan issued on Friday included a fair value estimate for Geron shares that was…

Jon C. Ogg | Jan 15, 2016 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: Best Buy, 3D Systems, EA, Gilead, Nokia, Shire, United Rentals and Many More

Friday's top analyst calls include Best Buy, 3D Systems, Electronic Arts, Gilead Sciences, Nokia, Shire and United Rentals.

Trey Thoelcke | Dec 23, 2015 at 10:40 AM EST

4 Ignored Biotech Stocks for 2016

Biotech gets a lot of sustained attention, but some stocks still fall through the cracks, either due to recent failures…

Lee Jackson | Dec 1, 2015 at 8:25 AM EST

Huge PowerShares ETF Rebalance Means Massive Buying for 4 Biotech Stocks

On the close Tuesday, the PowerShares Dynamic exchange traded funds (ETFs) are set for a rebalance. These four stocks that…

Chris Lange | Nov 14, 2014 at 11:35 AM EST

What Licensing Imetelstat Will Mean for Geron

Geron hasannounced that it entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech to develop and commercialize…

Chris Lange | Nov 3, 2014 at 12:25 PM EST

Is Geron Back From the Dead?

The FDA gave Geron some good news Monday morning when it removed the clinical hold on the its investigational new…

Paul Ausick | Apr 13, 2014 at 11:09 AM EDT

Nasdaq Falls Below 4,000 on Biotech, Technology Weakness

bfishshadow via Wikimedia CommonsSince the beginning of the year, the Nasdaq Composite Index has given up more than 4% of…

Paul Ausick | Mar 18, 2014 at 4:01 PM EDT

The 5 Stocks That Dominated the Market on Tuesday

thinkstockMarch 18, 2014: Markets opened higher on Tuesday and the number buyers rose throughout the day. There was something of…

Paul Ausick | Mar 12, 2014 at 4:01 PM EDT

The 4 Stocks That Dominated the Market on Wednesday

thinkstockMarch 12, 2014: Markets opened lower on Wednesday following a so-so trading day in Europe. Crude oil pulled back 2%…

Jon C. Ogg | Mar 12, 2014 at 9:45 AM EDT

Back to Normalcy at Geron

Geron is getting a reality check on Wednesday. After a recovery from years of disappointment, this is starting to feel…

1 2 3 4 … 6

Geron : GERN

All Geron Articles

Can This FDA Approval Keep Lifting Geron?

4 Companies That Destroyed Shareholders Last Week

Kroger, Whole Foods in Monday’s 52-Week Low Club

Is Geron Being Overly Punished?

10 Speculative Biotech and Biohealth Stocks With Massive Analyst Upside Calls

Can Geron Shares Still Ultimately Double?

Top Analyst Upgrades and Downgrades: Best Buy, 3D Systems, EA, Gilead, Nokia, Shire, United Rentals and Many More

4 Ignored Biotech Stocks for 2016

Huge PowerShares ETF Rebalance Means Massive Buying for 4 Biotech Stocks

What Licensing Imetelstat Will Mean for Geron

Is Geron Back From the Dead?

Nasdaq Falls Below 4,000 on Biotech, Technology Weakness

The 5 Stocks That Dominated the Market on Tuesday

The 4 Stocks That Dominated the Market on Wednesday

Back to Normalcy at Geron

Ripple’s $1.25 Billion Hidden Road Acquisition: One Year On, What’s Changed?

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

"Did you buy It from the mob?": Dave Ramsey hosts floored by 21-year-old's 30% truck loan

Ripple’s $1.25 Billion Hidden Road Acquisition: One Year On, What’s Changed?

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

Geron : GERN

All Geron Articles

Can This FDA Approval Keep Lifting Geron?

4 Companies That Destroyed Shareholders Last Week

Kroger, Whole Foods in Monday’s 52-Week Low Club

Is Geron Being Overly Punished?

10 Speculative Biotech and Biohealth Stocks With Massive Analyst Upside Calls

Can Geron Shares Still Ultimately Double?

Top Analyst Upgrades and Downgrades: Best Buy, 3D Systems, EA, Gilead, Nokia, Shire, United Rentals and Many More

4 Ignored Biotech Stocks for 2016

Huge PowerShares ETF Rebalance Means Massive Buying for 4 Biotech Stocks

What Licensing Imetelstat Will Mean for Geron

Is Geron Back From the Dead?

Nasdaq Falls Below 4,000 on Biotech, Technology Weakness

The 5 Stocks That Dominated the Market on Tuesday

The 4 Stocks That Dominated the Market on Wednesday

Back to Normalcy at Geron

Ripple’s $1.25 Billion Hidden Road Acquisition: One Year On, What’s Changed?

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Featured Reads

Why Your 401(k) Could Trigger a Tax Bomb in Retirement (And What to Do Now)

"Did you buy It from the mob?": Dave Ramsey hosts floored by 21-year-old's 30% truck loan